Kenneth Seier

10PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 16, 2025
Which Patients With Cancer Access Their Clinical Notes? A Disparities Analysis.

Susan Chimonas, Charlie White, Kenneth Seier

|Sep 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer.

Darren Cowzer, Madison Darmofal, Kenneth Seier

|Mar 18, 2025
Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine.

Yasin Khadem Charvadeh, Sahil D Doshi, Kenneth Seier

|Oct 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.

Sujana Movva, Kenneth Seier, Viswatej Avutu

|Oct 03, 2023
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced Sarcomas.

Evan Rosenbaum, Kenneth Seier, Martina Bradic

|Sep 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.

Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley

Pageof 2

Frequent Collaborators

4 joint publications

William D Tap

3 joint publications

Mary Louise Keohan

3 joint publications

Ciara M Kelly

3 joint publications

Mrinal M Gounder